McKesson market cap MCK
Share price times shares outstanding: what the whole company sells for, since 2009.
- Today, Nov 3, 2026
- $116.5B
- Highest close in our data
- $120.9B
- Feb 2026
McKesson is worth $116.5B at the close on Nov 3, 2026, at $999.41 a share.
That is up 11% over the last year and up 244% over five years.
Its highest close in our data was $120.9B in Feb 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $116.4B | $88.5B | $120.9B | +14% |
| 2025 | $102.2B | $73.3B | $108.8B | +40% |
| 2024 | $73.2B | $62.9B | $81.9B | +19% |
| 2023 | $61.6B | $46B | $62.4B | +16% |
| 2022 | $53.2B | $37.7B | $56.7B | +40% |
| 2021 | $38B | $27B | $38B | +36% |
| 2020 | $27.9B | $22.1B | $30.2B | +11% |
| 2019 | $25.1B | $21.5B | $28.2B | +17% |
| 2018 | $21.5B | $21.2B | $36.8B | −34% |
| 2017 | $32.5B | $28.3B | $35.3B | +2% |
| 2016 | $31.8B | $28.1B | $44.4B | −30% |
| 2015 | $45.4B | $41.1B | $55.7B | −7% |
| 2014 | $48.7B | $36.9B | $49.3B | +32% |
| 2013 | $37B | $23.6B | $38.1B | +63% |
| 2012 | $22.6B | $18.8B | $23.2B | +18% |
| 2011 | $19.1B | $17.3B | $21.4B | +7% |
| 2010 | $17.8B | $15.5B | $19B | +6% |
| 2009 | $16.7B | $13.6B | $17.2B | n/a |
Against its peers
Companies in Healthcare nearest McKesson's size, closest first, today.
| Company | Market cap |
|---|---|
| MCKMcKesson | $116.5B |
| SYKStryker | $118.6B |
| CVSCVS Health | $113.7B |
| MDTMedtronic | $126.7B |
| BMYBristol-Myers Squibb | $128.7B |
| HCAHCA Healthcare | $100.9B |
| REGNRegeneron Pharmaceuticals | $100B |
| VRTXVertex Pharmaceuticals | $137.1B |
| ELVElevance Health | $89.7B |
| ISRGIntuitive Surgical | $154.6B |
| DHRDanaher | $162.6B |
| Peer median | $122.7B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on McKesson
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.